SCHOTT Pharma AG & Co. KGaA (FRA: 1SXP)

Market Cap	3.66B
Revenue (ttm)	957.09M
Net Income (ttm)	149.69M
Shares Out	n/a
EPS (ttm)	0.99
PE Ratio	24.47
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	Feb 5, 2025

Volume	150
Open	23.72
Previous Close	23.70
Day's Range	23.72 - 23.72
52-Week Range	23.70 - 43.20
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Dec 12, 2024

About SCHOTT Pharma AG & Co. KGaA

SCHOTT Pharma AG & Co. KGaA develops, manufactures, and sells drug containment solutions and delivery systems for injectable drugs for pharmaceutical, biotechnology, and life science industries worldwide. The company offers prefillable glass or polymer syringes, glass vials, cartridges, and ampoules. Its syringe products include syriQ, a glass syringe for vaccines; syriQ BioPure, a glass syringe for biologics; syriQ BioPure silicone-free, a prefillable and silicone-free glass syringe for biologics; SCHOTT TOPPAC, a polymer syringe; SCHOTT TOPPA...

• Industry: Glass Containers
• Founded: 1884
• Employees: 4,646
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 1SXP

Financial Performance

In 2024, SCHOTT Pharma AG & Co. KGaA's revenue was 957.09 million, an increase of 6.51% compared to the previous year's 898.60 million. Earnings were 149.69 million, a decrease of -1.42%.